Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome
2017-002628-26Phase 3Completed
- Sponsor
- Zogenix, Inc.
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fenfluramine in Lennox-Gastaut syndrome (LGS), sponsored by Zogenix, Inc. Primary endpoint: Primary efficacy endpoint (Part 1 and overall study). Started Mar 2018; status: completed.
02
Drugs
fenfluramine
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on 2017-002628-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002628-26.